Abstract

Abstract Cell line drug screening datasets can be utilized for a range of different drug discovery applications from drug biomarker discovery to building translational models of drug response. Previously, we described three separate methodologies to (1) correct for general levels of drug sensitivity to enable drug-specific biomarker discovery, (2) predict clinical drug response in patients and (3) associate these predictions with clinical features to perform in vivo drug biomarker discovery. Here, we unite and update these methodologies into one R package (oncoPredict) to facilitate the development and adoption of these tools. This new OncoPredict R package can be applied to various in vitro and in vivo contexts for drug and biomarker discovery.

Keywords

BiomarkerBiomarker discoveryDrug discoveryDrugDrug responseIn vivoCancer cell linesDrug developmentComputational biologyComputer scienceAnticancer drugMedicineBioinformaticsCancerPharmacologyBiologyInternal medicineProteomicsCancer cell

MeSH Terms

Antineoplastic AgentsBiomarkersTumorCell LineTumorHumansSoftware

Affiliated Institutions

Related Publications

Publication Info

Year
2021
Type
article
Volume
22
Issue
6
Citations
1489
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1489
OpenAlex
71
Influential
1340
CrossRef

Cite This

Danielle Maeser, Robert F. Gruener, R. Stephanie Huang (2021). oncoPredict: an R package for predicting <i>in vivo</i> or cancer patient drug response and biomarkers from cell line screening data. Briefings in Bioinformatics , 22 (6) . https://doi.org/10.1093/bib/bbab260

Identifiers

DOI
10.1093/bib/bbab260
PMID
34260682
PMCID
PMC8574972

Data Quality

Data completeness: 90%